Chong Woo Yoo
Papers
1
Total Citations
11
H-Index
1
About
Chong Woo Yoo is a distinguished researcher whose work bridges oncology and advanced proteomic technologies, with a primary focus on lung cancer diagnostics and biomarker discovery. His most-cited study, "Matrix‐assisted laser desorption/ionization mass spectrometry reveals decreased calcyclin expression in small cell lung cancer" (2011, 11 citations), represents a pivotal contribution to the field. In this work, Yoo pioneered the use of MALDI mass spectrometry on bronchoscopic biopsy samples—rather than traditional surgical specimens—to identify a proteomic signature that could aid in early lung cancer diagnosis. He specifically demonstrated that decreased calcyclin expression is a hallmark of small cell lung cancer, offering a novel molecular marker for this aggressive disease. This approach was groundbreaking because it showed that diagnostic proteomic profiles could be obtained from minimally invasive biopsy samples, potentially accelerating diagnosis and treatment decisions. Yoo’s research has been cited by subsequent studies exploring proteomic patterns in lung cancer, underscoring its influence on translational oncology. His work exemplifies how integrating cutting-edge mass spectrometry with clinical sampling can yield actionable insights, making him a notable figure in cancer proteomics and precision medicine.
Research Focus
Key Achievements
Top Papers
- 1